big money statement for bta

http://www.bloomberg.com/apps/news?pid=20601087&sid=aDqqXnZ.Jdxc&refer=home

"The U.S. Centers for Disease Control and Prevention recommends that patients take Glaxo’s Relenza, or an unspecified anti-viral drug combination, rather than Roche’s Tamiflu, Martin Meltzer, a senior health economist at the CDC, said at a meeting on flu vaccines in Cannes, France. Most seasonal flu variants of H1N1 circulating globally are resistant to Tamiflu."